You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDH wild-type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Glioblastoma Trial in Köln, München, Münster (5-aminolevulinic acid)

Recruiting
  • Glioblastoma
  • 5-aminolevulinic acid
  • Köln, Germany
  • +2 more
Feb 2, 2022

Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)

Not yet recruiting
  • Glioblastoma
  • Dose escalation of radiation dose beyond the therapeutic standard
  • (no location specified)
May 13, 2023

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Initial Radiological Diagnosis Eligible for Tumor Resection, Initial Radiological Diagnosis Compatible With Newly Diagnosed

Recruiting
  • Initial Radiological Diagnosis Eligible for Tumor Resection
  • +2 more
  • SonoCloud-9 (SC9) device
  • Temozolomide according Stupp protocol
  • Leuven, Belgium
  • +6 more
Mar 28, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab and irinotecan
  • (no location specified)
Jul 26, 2023

Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

Recruiting
  • Polyneuropathy
  • Amyloidosis
  • ECG + echocardiography
  • Answering questionnaires
  • Jette, Belgium Capital City, Belgium
    UZ Brussel
Jul 14, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Lung Cancer Trial (Savolitinib, Durvalumab)

Recruiting
  • Lung Cancer
  • Beijing, China
  • +2 more
Jan 11, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Cholesterol Levels Trial in Alexandroupolis (Lacticaseibacillus with oats, Plain oats)

Active, not recruiting
  • Cholesterol Levels
  • Lacticaseibacillus with oats
  • Plain oats
  • Alexandroupolis, East Macedonia And Thrace, Greece
    Democritus University of Thrace
Oct 25, 2023

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Ovarian Cancer Trial (Huaier granule)

Not yet recruiting
  • Ovarian Cancer
  • Huaier granule
  • (no location specified)
Feb 28, 2023

Metastatic Breast Cancer Trial (Estradiol)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Feb 6, 2023

Wild-type Amyloid Cardiopathy Trial in Bordeaux, Nantes, Toulouse (electromyogram)

Recruiting
  • Wild-type Amyloid Cardiopathy
  • electromyogram
  • Bordeaux, France
  • +2 more
Jul 4, 2022